Lexaria Bioscience (LEXX)
(Delayed Data from NSDQ)
$3.13 USD
-0.18 (-5.44%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $3.11 -0.02 (-0.64%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/19/24 |
---|---|
Current Quarter | -0.11 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | -44.44% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.42 |
Next Year | -0.35 |
EPS (TTM) | -0.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.15M | 0.20M | 0.53M | 0.79M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 0.15M | 0.20M | 0.53M | 0.98M |
Low Estimate | 0.15M | 0.20M | 0.53M | 0.60M |
Year ago Sales | 0.00M | 0.15M | 0.23M | 0.53M |
Year over Year Growth Est. | NA | 33.33% | 134.52% | 49.06% |
Earnings Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.11 | -0.09 | -0.42 | -0.35 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.12 | -0.09 | -0.44 | -0.36 |
High Estimate | -0.09 | -0.09 | -0.40 | -0.33 |
Low Estimate | -0.12 | -0.09 | -0.44 | -0.36 |
Year ago EPS | -0.12 | -0.13 | -1.01 | -0.42 |
Year over Year Growth Est. | 8.33% | 30.77% | 58.42% | 17.86% |
Agreement - Estimate Revisions
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Current | -0.11 | -0.09 | -0.42 | -0.35 |
7 Days Ago | -0.11 | -0.09 | -0.42 | -0.35 |
30 Days Ago | -0.09 | -0.07 | -0.37 | -0.35 |
60 Days Ago | -0.13 | NA | -0.46 | -0.41 |
90 Days Ago | -0.13 | NA | -0.46 | -0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.09 | -0.42 | -0.35 |
Zacks Consensus Estimate | -0.11 | -0.09 | -0.42 | -0.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (5/2024) |
Quarter Ending (2/2024) |
Quarter Ending (11/2023) |
Quarter Ending (8/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.06 | -0.13 | -0.12 | NA |
Estimate | -0.09 | NA | NA | -0.17 | NA |
Difference | -0.04 | NA | NA | 0.05 | 0.01 |
Surprise | -44.44% | NA | NA | 29.41% | -7.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more